Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response.
MS disease activity in RESTORE: A randomized 24-week natalizumab treatment interruption study.
Comparative efficacy of interferon β versus glatiramer acetate for relapsing-remitting multiple sclerosis.
American Academy of Neurology: Breakthroughs in Neurology
Cognitive Test Analysis May Determine Reliable MS Change Over Time
Experimental models of spontaneous autoimmune disease in the central nervous system.
Episode 23 with Professor Aksel Siva discussing radiologically isolated syndrome (RIS)
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
The neuroendocrine axis in patients with multiple sclerosis.
Extracellular Cues Influencing Oligodendrocyte Differentiation and (Re)myelination.
Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?
Pregnancy and multiple sclerosis.
Suppressed RNA-Polymerase 1 Pathway Is Associated with Benign Multiple Sclerosis.
A New Colour Reaction on Copper and Certain Carbonyl Compounds
Cost-Effectiveness of Treatments for Relapsing Remitting Multiple Sclerosis: A French Societal Perspective.
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial.
Cerebrospinal fluid data compilation and knowledge-based interpretation of bacterial, viral, parasitic, oncological, chronic inflammatory and demyelinating diseases. Diagnostic patterns not to be missed in neurology and psychiatry.
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial.
TECFIDERA prescribing information
Oral BG-12 (dimethyl fumarate) significantly reduced multiple sclerosis (MS) relapses and disability progression in DEFINE Phase 3 clinical trial
Episode 39 with Dr. Joseph Berger on diagnostic dilemmas in MS
17beta-estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice.
Effects of dimethyl fumarate on neuroprotection and immunomodulation.
New diagnostic criteria for multiple sclerosis: guidelines for research protocols.
Health-related quality of life in multiple sclerosis: Direct and indirect effects of comorbidity.

Pages